Is it Time for a New Approach to Implantable Cardioverter-Defibrillator Replacement?

With the expansion of indications for implantable cardioverter-defibrillators (ICDs) for primary and secondary prevention of sudden cardiac death, >100,000 implantations of these devices are performed annually in the United States [(1,2)][1]. Of these, ∼25% are replacements of existing devices